Clinical Trials on Snake Bite in Hong Kong
Total 1352 results
-
AnaborexTerminatedAnorexia | Carcinoma, Non-Small-Cell Lung | Weight Loss | CachexiaChina, Taiwan
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedMetastatic Cancer | Liver CancerUnited States, China
-
National Healthcare Group, SingaporeChinese University of Hong Kong; Tan Tock Seng Hospital; Changi General HospitalCompletedStomach Cancer | Gastric Cancer | GastrectomySingapore, Hong Kong
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Head and Neck Neoplasms | Colorectal NeoplasmsAustralia, Hong Kong
-
National University Hospital, SingaporePrince of Wales Hospital, Shatin, Hong Kong; Apollo Gleneagles Hospitals, KolkataUnknownGastric Cancer | Colon CancerSingapore, India, China
-
Chinese University of Hong KongRecruitingGastric Cancer | Intestinal Metaplasia | Atrophic GastritisHong Kong, Japan, Singapore, Thailand
-
Shanghai Chest HospitalChang Gung Memorial Hospital; Tianjin Medical University Cancer Institute and... and other collaboratorsUnknown
-
Chinese University of Hong KongCompletedSquamous Cell Carcinoma of EsophagusChina
-
Hoffmann-La RocheCompletedLiver CancerHong Kong, Taiwan, Singapore, Australia
-
SCG Cell Therapy Pte. Ltd.RecruitingHepatocellular Carcinoma Recurrent | Hepatitis B Virus Related Hepatocellular CarcinomaUnited States, Singapore, Hong Kong
-
Galvanize Therapeutics, Inc.TerminatedCancer of Lung, Kidney or LiverHong Kong, Spain, Netherlands
-
Novartis PharmaceuticalsTerminatedHepatocellular CarcinomaHong Kong, Taiwan, Thailand
-
GlaxoSmithKlineCompletedCarcinoma, HepatocellularTaiwan, Thailand, Hong Kong
-
GlaxoSmithKlineCompletedCarcinoma, HepatocellularTaiwan, United States, Hong Kong
-
AstraZenecaCompletedCancer | Advanced Hepatocellular CarcinomaKorea, Republic of, Hong Kong
-
Galvanize Therapeutics, Inc.Active, not recruitingNon Small Cell Lung CancerHong Kong, Spain, Netherlands
-
Light Sciences OncologyCompletedCarcinoma, Hepatocellular | Liver NeoplasmsTaiwan, Hong Kong, Singapore
-
PROCEPT BioRoboticsRecruitingBenign Prostatic Hyperplasia | Localized Prostate CancerLebanon, Hong Kong, United States
-
Matrix PharmaceuticalUnknown
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.RecruitingNon-small Cell Lung Cancer | ALK-Positive Lung CancerKorea, Republic of, Hong Kong, Malaysia, Singapore
-
SanofiCompletedColonic NeoplasmsHong Kong, Korea, Republic of, Taiwan, Thailand, China
-
Chinese University of Hong KongChangi General Hospital; Kosin University Gospel Hospital; Shizuoka Cancer Center and other collaboratorsCompletedEarly Gastric Cancer | Gastric NeoplasmJapan, Singapore, Korea, Republic of, Hong Kong
-
Hoffmann-La RocheCompletedNasopharyngeal CancerHong Kong, Thailand, Indonesia, Taiwan, Malaysia
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastHong Kong, China
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedGastric CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
National University Hospital, SingaporeNational Taiwan University Hospital; Chinese University of Hong Kong; Singapore... and other collaboratorsActive, not recruitingStomach NeoplasmTaiwan, United States, Singapore, Hong Kong, Japan, Korea, Republic of
-
Cullinan Oncology, LLCNational Cancer Institute (NCI)TerminatedNasopharyngeal Carcinoma | Nasopharyngeal CancerFrance, Singapore, United States, China, Hong Kong
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
Ligand PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan
-
R-PharmCompletedStomach NeoplasmsKorea, Republic of, Taiwan, Japan, Singapore, Hong Kong
-
Novartis PharmaceuticalsWithdrawnAdvanced Hepatocellular CarcinomaGermany, Australia, Hong Kong, Switzerland, Spain, France, United States
-
Boston Scientific CorporationRecruitingPancreatic Diseases | Bile Duct Diseases | Hepatic DiseaseUnited States, India, China, Hong Kong
-
National Medical Research Council (NMRC), SingaporeCompletedLiver CancerNew Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
-
National Cancer Centre, SingaporeSingapore General HospitalRecruitingNon-Small Cell Lung Cancer | Lung CancerThailand, Singapore, Hong Kong, Brunei Darussalam, India, Malaysia
-
University of WashingtonNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Cervical Undifferentiated Carcinoma | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage... and other conditionsUnited States, Hong Kong, Canada
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
Boston Scientific CorporationCompletedPancreatic Diseases | Bile Duct Diseases | Bile Duct ObstructionUnited States, Belgium, Italy, Canada, Germany, Hong Kong, India
-
Progen PharmaceuticalsTerminatedCancer | Hepatocellular Carcinoma | Primary Liver Cancer | Liver Cancer | HepatomaHong Kong, Singapore, United States, Australia, Canada, Italy, Malaysia, Spain, Taiwan, Thailand
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Hong Kong, Taiwan, Singapore
-
National Cancer Institute (NCI)CompletedRecurrent Squamous Cell Carcinoma of the Nasopharynx | Stage IV Squamous Cell Carcinoma of the NasopharynxUnited States, Singapore, China
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan, Korea, Republic of
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
PfizerTerminatedBreast CancerUnited States, Belgium, Hungary, China, Hong Kong, Poland, Singapore